Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-061920)

Filing Details

Accession Number:: 0001209191-19-061920
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-12-26 16:06:34
Reporting Period:: 2019-12-23

Accepted Time:: 2019-12-26 16:06:34
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1567514	Intra-Cellular Therapies Inc.	ITCI	Pharmaceutical Preparations (2834)	364742850

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1585697	J. Lawrence Hineline	C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016	Svp Of Finance Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-12-23	9,600	$2.74	34,832	No	4	M	Direct
Common Stock	Disposition	2019-12-23	9,600	$25.50	25,232	No	4	S	Direct
Common Stock	Disposition	2019-12-23	5,432	$25.50	19,800	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-12-23	9,600	$0.00	9,600	$2.74

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2020-06-10	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2018.
All shares underlying this option have vested.